SCHEMBL28944843

SCHEMBL28944843

NC(=O)C1CCN(OC=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.47
GAA P10253 1/20 0.46
MEN1 O00255 1/20 0.41
APEX1 P27695 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CHRM1 P11229 1/20 0.39
ALDH1A1 P00352 3/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 2/20 0.36
HTT P42858 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
LTA4H P09960 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28793591 0.78 SMN1; SMN2 (0.32) SMN1; SMN2GAA
SCHEMBL12706380 0.77 SMN1; SMN2 (0.53) SMN1; SMN2GAAKMT2ACHRM1ALDH1A1
SCHEMBL4261397 0.76 SMN1; SMN2 (0.44) SMN1; SMN2GAAMEN1APEX1KMT2A
SCHEMBL1712556 0.74 SMN1; SMN2 (0.50) SMN1; SMN2GAAMEN1APEX1KMT2A
SCHEMBL8483160 0.73 SMN1; SMN2 (0.50) SMN1; SMN2GAAMEN1APEX1KMT2A
SCHEMBL4594409 0.73
SCHEMBL18166977 0.73 GPR119 (0.36)
SCHEMBL28105332 0.72 GAA (0.61) SMN1; SMN2GAACHRM1ALDH1A1CYP2C19
SCHEMBL27770659 0.71 SMN1; SMN2 (0.43) SMN1; SMN2GAATDP1CHRM1ALDH1A1
SCHEMBL7436436 0.71 SMN1; SMN2 (0.43) SMN1; SMN2GAAMEN1APEX1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115335373-B Compounds and uses thereof 福宏治疗公司 2025-05-20 CN disclosed
EP-4463452-A2 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2024-11-20 EP disclosed
WO-2023177700-A2 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2023-09-21 WO disclosed
WO-2023077441-A1 METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION RANOK THERAPEUTICS (HANGZHOU) CO. LTD. (CN) 2023-05-11 WO disclosed
CN-115335369-A GEM-disubstituted piperidine melanocortin subtype-2 receptor (MC 2R) antagonists and uses thereof 克林提克斯医药股份有限公司 2022-11-11 CN disclosed